HHC vs THC: What Is the Difference?
Published: 18 April 2023
Last Updated: 22 July 2026
Last Reviewed: 22 July 2026
Author: Weed Supermarket Editorial Team
HHC and THC are cannabinoids with similar chemical structures, but they are not identical. They also differ in how they are produced, how extensively they have been researched and how they are treated under drug-control frameworks.
HHC, or hexahydrocannabinol, has appeared in a growing range of products across Europe in recent years. It has sometimes been marketed as a milder or legally unrestricted alternative to THC, but these descriptions can be misleading.
This guide explains the main differences between HHC and THC, the limitations of current research and the developing legal position in the United Kingdom.
What Is HHC?
HHC stands for hexahydrocannabinol. Although very small amounts may occur naturally in cannabis, commercially available HHC is generally produced through chemical processing and is therefore commonly described as a semi-synthetic cannabinoid.
Commercial production often begins with CBD extracted from low-THC cannabis or hemp. The CBD is chemically converted into HHC through a manufacturing process rather than simply being extracted from the plant in meaningful quantities.
HHC was first identified in the European market during the early 2020s and has since been monitored as a new psychoactive substance.
What Is THC?
THC commonly refers to delta-9-tetrahydrocannabinol, the principal psychoactive cannabinoid associated with cannabis.
Unlike commercially produced HHC, delta-9-THC occurs naturally in cannabis. It interacts with cannabinoid receptors within the body and can affect perception, mood, coordination, memory and reaction time.
THC is a controlled drug in the United Kingdom, except where a specific legal exemption or appropriate licence applies.
HHC vs THC: The Main Differences
The key differences between HHC and THC include their origin, chemical structure, available research and legal treatment.
- Origin: Delta-9-THC occurs naturally in cannabis, while commercial HHC is usually produced through chemical conversion.
- Chemical structure: HHC has a hydrogenated chemical structure that distinguishes it from THC.
- Research: THC has been studied much more extensively than HHC.
- Product consistency: Unregulated HHC products may vary in strength, purity and chemical composition.
- Legal treatment: THC is controlled under UK drugs legislation, while the position surrounding HHC has been developing through the Psychoactive Substances Act and proposed changes to the Misuse of Drugs Act.
Is HHC Psychoactive?
Yes. HHC is considered capable of producing psychoactive effects.
Available evidence indicates that HHC can interact with CB1 cannabinoid receptors, which are also involved in the psychoactive effects associated with THC. However, experiences can vary considerably depending on the product, dose, method of use and individual.
Claims that HHC is consistently weaker, gentler or safer than THC should be treated cautiously. There is not enough reliable clinical evidence to support simple comparisons of potency or safety across all products.
Is HHC Safer Than THC?
There is currently insufficient evidence to conclude that HHC is safer than THC.
Reported adverse effects associated with HHC and related semi-synthetic cannabinoids include:
- Anxiety and panic reactions.
- Drowsiness and confusion.
- Hallucinations or altered perception.
- Nausea and vomiting.
- Increased heart rate or palpitations.
- Dizziness and impaired coordination.
More serious reactions have also been reported internationally, although the available evidence remains incomplete.
An additional concern is product composition. Chemically converted cannabinoids may contain unexpected compounds, manufacturing by-products or contaminants where appropriate quality controls and independent testing are absent.
Does HHC Have Proven Medical Benefits?
HHC does not have an established evidence base supporting the broad therapeutic claims sometimes made in online marketing.
Claims relating to pain, anxiety, sleep, appetite, depression, neurological conditions or other health concerns should not be treated as proven medical benefits. Much of the information circulating online is based on personal reports, laboratory findings or comparisons with THC rather than robust clinical trials involving HHC.
No cannabinoid product should be used as a substitute for appropriate medical assessment or prescribed treatment.
Is HHC Legal in the UK?
The UK legal position should not be simplified to either “legal” or “unregulated”.
UK authorities have stated that psychoactive semi-synthetic cannabinoids not already captured by the Misuse of Drugs Act may be subject to the Psychoactive Substances Act 2016. This legislation restricts the production, supply, importation and exportation of psychoactive substances intended for human consumption, subject to defined exemptions.
In 2025, the Advisory Council on the Misuse of Drugs recommended that HHC and several related compounds be specifically controlled as Class B drugs and placed in Schedule 1 of the Misuse of Drugs Regulations.
The UK Government accepted that recommendation and stated that it would implement the change when parliamentary time allows. Legislation can change, so readers should consult the latest official government guidance rather than relying on product marketing or older articles.
Why Laboratory Testing Matters
Laboratory testing is especially important where cannabinoids have been produced through chemical conversion.
Appropriate analysis may help identify:
- Which cannabinoids are present.
- The concentration of each detected compound.
- Unexpected reaction by-products.
- Residual solvents or contaminants.
- Differences between batches.
A product label alone does not independently confirm its chemical composition or legal status.
Our wider approach is explained in the UK Compliance & Laboratory Testing guide.
HHC, CBD and Other Cannabinoids
HHC should not be confused with CBD. CBD is not considered intoxicating in the same way as THC or HHC, although consumer CBD products remain subject to applicable UK product, food and controlled-drug requirements.
It is also important to distinguish HHC from naturally occurring cannabinoids such as CBG and CBN.
Further introductory information is available in our guides:
Related Guides
Frequently Asked Questions
Is HHC the same as THC?
No. HHC and THC have related chemical structures, but they are different cannabinoids. Commercial HHC is generally produced through chemical conversion, while delta-9-THC occurs naturally in cannabis.
Does HHC cause psychoactive effects?
Yes. Evidence indicates that HHC is psychoactive and can produce effects resembling those associated with THC.
Is HHC weaker than THC?
HHC is frequently marketed as weaker than THC, but there is insufficient reliable evidence to apply that description consistently. Effects may vary between products and individuals.
Is HHC safe?
There is not enough clinical evidence to establish HHC as safe. Adverse effects have been reported, and unregulated products may present additional risks relating to strength, contaminants and manufacturing by-products.
Is HHC legal to sell in the UK?
Psychoactive HHC products may be subject to the Psychoactive Substances Act 2016. The government has also accepted a recommendation to specifically control HHC as a Class B drug. Businesses and consumers should obtain current professional legal advice rather than assuming HHC is unrestricted.
Does HHC have proven health benefits?
No broad therapeutic benefits have been established through sufficient high-quality clinical research. Health claims made about HHC should therefore be treated cautiously.
Final Thoughts
HHC and THC are chemically related psychoactive cannabinoids, but HHC should not be regarded as a proven safer, milder or legally unrestricted alternative to THC.
Research into HHC remains limited, product composition can vary and UK authorities have identified potential health and social harms. The government has also accepted recommendations for tighter legal control.
Consumers should rely on current official information, independent scientific evidence and appropriate professional advice rather than promotional claims made by sellers.
Further Reading
- UK Government – Semi-Synthetic Cannabinoids
- European Union Drugs Agency – HHC and Related Substances
- World Health Organization – Expert Committee on Drug Dependence
- UK Government – Cannabis, CBD and Cannabinoid Licensing
Compliance Statement
This article is provided for general educational and informational purposes only. It is not medical or legal advice and does not encourage the possession, supply or use of controlled or psychoactive substances. Laws and scientific evidence can change, and readers should consult current official guidance and appropriately qualified professionals.